Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |